STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Operating margin
STERIS plc's operating margin over the twelve months to 30 June 2026 was 18.9%, up 0.4 percentage points from fiscal 2026 (18.6%). Over the past ten years it has ranged from 8.66% (fiscal 2017) to 18.6% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | 18.6% | 2.69 |
| FY2025 | 15.9% | (0.40) |
| FY2024 | 16.3% | (1.17) |
| FY2023 | 17.4% | 6.13 |
| FY2022 | 11.3% | (6.34) |
| FY2021 | 17.7% | (0.07) |
| FY2020 | 17.7% | 2.95 |
| FY2019 | 14.8% | (0.49) |
| FY2018 | 15.3% | 6.60 |
| FY2017 | 8.66% | (0.85) |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 19.2% | (0.79) |
| Mar 2026 | 19.9% | 1.67 |
| Dec 2025 | 18.3% | 0.07 |
| Sep 2025 | 18.2% | 0.52 |
| 42 more quarters | Free account |
Against its own ten years
Low 8.66%
High 18.6%
Ten-year median
15.6%
Current reading's percentile
100
Operating margin against peers
| Company | Operating margin |
|---|---|
| DXCM DexCom, Inc. compare | 22.9% |
| STE STERIS plc | 18.9% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 14.2% |
| GEHC GE HealthCare Technologies Inc. compare | 12.9% |
| PEN Penumbra, Inc. compare | 12.5% |
| PHG Koninklijke Philips N.V. compare | 9.64% |
| BIO Bio-Rad Laboratories, Inc. compare | 2.05% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 2.05% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −15.0% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement